Prevalence of comorbidities with peanut allergy: results from two phase 3, randomized, double-blind, placebo-controlled trials (PALISADE and RAMSES)

• Kirsten Beyer,
• Alan Goldsobel,
• Douglas Johnston,
• Noelle M. Griffin,
• Kari R. Brown,
• Trinh Pham,
• Andrea Vereda,
• Dareen Siri,
• George Du Toit

Affiliations

Kirsten Beyer

Charité Universitätsmedizin Berlin, Klinik für Pädiatrie m. S. Pneumologie und Immunologie, Berlin, Germany

Alan Goldsobel

Allergy & Asthma Associates of Northern California, San Jose, CA, San Jose, United States

Douglas Johnston

Asthma & Allergy Specialists, P.A., Charlotte, United States

Noelle M. Griffin

Aimmune Therapeutics, Brisbane, United States

Kari R. Brown

Aimmune Therapeutics, Brisbane, United States

Trinh Pham

Aimmune Therapeutics, Brisbane, United States

Andrea Vereda

Aimmune Therapeutics, London, United States

Dareen Siri

Midwest Allergy Sinus Asthma/SWIA Clinical Research Center, Normal, United States

George Du Toit

Guy's and St. Thomas' NHS Foundation Trust, London, United States